SS
SOPH icon

Steve Schonfeld’s SOPHiA GENETICS SOPH Stock Holding History

Steve Schonfeld’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-61,200
Closed -$302K – 2539
2024
Q1 		$302K Buy
61,200
+21,000
+52% +$101K ﹤0.01% 1642
2023
Q4 		$189K Buy
+40,200
New +$150K ﹤0.01% 1544

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $369M AUM 45.79% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Steve Schonfeld's SOPH Position: Q2 2024 in Review

Steve Schonfeld sold out of SOPHiA GENETICS (SOPH) in Q2 2024, closing a stake of 61,200 shares — an estimated $302K sold.

Steve Schonfeld first reported a position in SOPH in Q4 2023 and held it in 2 quarters. The position peaked at $302K in Q1 2024. 31 funds tracked by Wall St. Rank hold SOPH as of Q2 2024.

  • Steve Schonfeld reported no remaining SOPHiA GENETICS position as of Q2 2024 after selling out during the quarter.
  • Steve Schonfeld sold 61,200 SOPHiA GENETICS shares in Q2 2024, an estimated $302K.
  • Steve Schonfeld first reported a position in SOPHiA GENETICS in Q4 2023 and held it in 2 quarters.
  • Steve Schonfeld's SOPHiA GENETICS position peaked at $302K in Q1 2024.
  • 31 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.